Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of tirapazamine plus cyclophosphamide in treating
children who have refractory solid tumors. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die. Combining more than one drug may
kill more tumor cells.